Cargando…
Immunomodulation as a Protective Strategy in Chronic Otitis Media
INTRODUCTION: Major features of the pathogenesis in otitis media, the most common disease in childhood, include hyperplasia of the middle ear mucosa and infiltration by leukocytes, both of which typically resolve upon bacterial clearance via apoptosis. Activation of innate immune receptors during th...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005906/ https://www.ncbi.nlm.nih.gov/pubmed/35433505 http://dx.doi.org/10.3389/fcimb.2022.826192 |
_version_ | 1784686558793695232 |
---|---|
author | Leichtle, Anke Kurabi, Arwa Leffers, David Därr, Markus Draf, Clara Sophia Ryan, Allen Frederic Bruchhage, Karl-Ludwig |
author_facet | Leichtle, Anke Kurabi, Arwa Leffers, David Därr, Markus Draf, Clara Sophia Ryan, Allen Frederic Bruchhage, Karl-Ludwig |
author_sort | Leichtle, Anke |
collection | PubMed |
description | INTRODUCTION: Major features of the pathogenesis in otitis media, the most common disease in childhood, include hyperplasia of the middle ear mucosa and infiltration by leukocytes, both of which typically resolve upon bacterial clearance via apoptosis. Activation of innate immune receptors during the inflammatory process leads to the activation of intracellular transcription factors (such as NF-κB, AP-1), which regulate both the inflammatory response and tissue growth. We investigated these leading signaling pathways in otitis media using mouse models, human samples, and human middle ear epithelial cell (HMEEC) lines for therapeutic immunomodulation. METHODS: A stable otitis media model in wild-type mice and immunodeficient KO-mice, as well as human tissue samples from chronic otitis media, skin from the external auditory canal and middle ear mucosa removed from patients undergoing ear surgery, were studied. Gene and protein expression of innate immune signaling molecules were evaluated using microarray, qPCR and IHC. In situ apoptosis detection determined the apoptotic rate. The influence of bacterial infection on immunomodulating molecules (TNFα, MDP, Tri-DAP, SB203580, Cycloheximide) in HMEEC was evaluated. HMEEC cells were examined after bacterial stimulation/inhibition for gene expression and cellular growth. RESULTS: Persistent mucosal hyperplasia of the middle ear mucosa in chronic otitis media resulted from gene and protein expression of inflammatory and apoptotic genes, including NODs, TNFα, Casp3 and cleaved Casp3. In clinical chronic middle ear samples, these molecules were modulated after a specific stimulation. They also induced a hyposensitive response after bacterial/NOD-/TLR-pathway double stimulation of HMEEC cells in vitro. Hence, they might be suitable targets for immunological therapeutic approaches. CONCLUSION: Uncontrolled middle ear mucosal hyperplasia is triggered by TLRs/NLRs immunoreceptor activation of downstream inflammatory and apoptotic molecules. |
format | Online Article Text |
id | pubmed-9005906 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90059062022-04-14 Immunomodulation as a Protective Strategy in Chronic Otitis Media Leichtle, Anke Kurabi, Arwa Leffers, David Därr, Markus Draf, Clara Sophia Ryan, Allen Frederic Bruchhage, Karl-Ludwig Front Cell Infect Microbiol Cellular and Infection Microbiology INTRODUCTION: Major features of the pathogenesis in otitis media, the most common disease in childhood, include hyperplasia of the middle ear mucosa and infiltration by leukocytes, both of which typically resolve upon bacterial clearance via apoptosis. Activation of innate immune receptors during the inflammatory process leads to the activation of intracellular transcription factors (such as NF-κB, AP-1), which regulate both the inflammatory response and tissue growth. We investigated these leading signaling pathways in otitis media using mouse models, human samples, and human middle ear epithelial cell (HMEEC) lines for therapeutic immunomodulation. METHODS: A stable otitis media model in wild-type mice and immunodeficient KO-mice, as well as human tissue samples from chronic otitis media, skin from the external auditory canal and middle ear mucosa removed from patients undergoing ear surgery, were studied. Gene and protein expression of innate immune signaling molecules were evaluated using microarray, qPCR and IHC. In situ apoptosis detection determined the apoptotic rate. The influence of bacterial infection on immunomodulating molecules (TNFα, MDP, Tri-DAP, SB203580, Cycloheximide) in HMEEC was evaluated. HMEEC cells were examined after bacterial stimulation/inhibition for gene expression and cellular growth. RESULTS: Persistent mucosal hyperplasia of the middle ear mucosa in chronic otitis media resulted from gene and protein expression of inflammatory and apoptotic genes, including NODs, TNFα, Casp3 and cleaved Casp3. In clinical chronic middle ear samples, these molecules were modulated after a specific stimulation. They also induced a hyposensitive response after bacterial/NOD-/TLR-pathway double stimulation of HMEEC cells in vitro. Hence, they might be suitable targets for immunological therapeutic approaches. CONCLUSION: Uncontrolled middle ear mucosal hyperplasia is triggered by TLRs/NLRs immunoreceptor activation of downstream inflammatory and apoptotic molecules. Frontiers Media S.A. 2022-03-30 /pmc/articles/PMC9005906/ /pubmed/35433505 http://dx.doi.org/10.3389/fcimb.2022.826192 Text en Copyright © 2022 Leichtle, Kurabi, Leffers, Därr, Draf, Ryan and Bruchhage https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular and Infection Microbiology Leichtle, Anke Kurabi, Arwa Leffers, David Därr, Markus Draf, Clara Sophia Ryan, Allen Frederic Bruchhage, Karl-Ludwig Immunomodulation as a Protective Strategy in Chronic Otitis Media |
title | Immunomodulation as a Protective Strategy in Chronic Otitis Media |
title_full | Immunomodulation as a Protective Strategy in Chronic Otitis Media |
title_fullStr | Immunomodulation as a Protective Strategy in Chronic Otitis Media |
title_full_unstemmed | Immunomodulation as a Protective Strategy in Chronic Otitis Media |
title_short | Immunomodulation as a Protective Strategy in Chronic Otitis Media |
title_sort | immunomodulation as a protective strategy in chronic otitis media |
topic | Cellular and Infection Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005906/ https://www.ncbi.nlm.nih.gov/pubmed/35433505 http://dx.doi.org/10.3389/fcimb.2022.826192 |
work_keys_str_mv | AT leichtleanke immunomodulationasaprotectivestrategyinchronicotitismedia AT kurabiarwa immunomodulationasaprotectivestrategyinchronicotitismedia AT leffersdavid immunomodulationasaprotectivestrategyinchronicotitismedia AT darrmarkus immunomodulationasaprotectivestrategyinchronicotitismedia AT drafclarasophia immunomodulationasaprotectivestrategyinchronicotitismedia AT ryanallenfrederic immunomodulationasaprotectivestrategyinchronicotitismedia AT bruchhagekarlludwig immunomodulationasaprotectivestrategyinchronicotitismedia |